Scott Dreyer - 23 May 2024 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Signature
/s/ Shirley R. Kuhlmann as Attorney-In-Fact For Scott Dreyer
Issuer symbol
COLL
Transactions as of
23 May 2024
Net transactions value
-$1,860,298
Form type
4
Filing time
28 May 2024, 16:22:47 UTC
Previous filing
28 Feb 2024
Next filing
12 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Options Exercise $1,230,552 +51,209 +37% $24.03 190,127 23 May 2024 Direct
transaction COLL Common Stock Sale $1,732,093 -51,209 -27% $33.82 138,918 23 May 2024 Direct F1
transaction COLL Common Stock Options Exercise $571,698 +23,791 +17% $24.03 162,709 24 May 2024 Direct
transaction COLL Common Stock Sale $1,930,455 -56,807 -35% $33.98 105,902 24 May 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COLL Stock Option (Right to Purchase) Options Exercise $0 -51,209 -68% $0.000000 23,791 23 May 2024 Common Stock 51,209 $24.03 Direct F3
transaction COLL Stock Option (Right to Purchase) Options Exercise $0 -23,791 -100% $0.000000* 0 24 May 2024 Common Stock 23,791 $24.03 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.36 to $34.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.68 to $34.25, inclusive.
F3 The option is fully vested and exercisable.